"Lung Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the LUNG.
| Descriptor ID |
D008175
|
| MeSH Number(s) |
C04.588.894.797.520 C08.381.540 C08.785.520
|
| Concept/Terms |
Lung Neoplasms- Lung Neoplasms
- Pulmonary Neoplasms
- Neoplasms, Lung
- Lung Neoplasm
- Neoplasm, Lung
- Neoplasms, Pulmonary
- Neoplasm, Pulmonary
- Pulmonary Neoplasm
Lung Cancer- Lung Cancer
- Cancer, Lung
- Cancers, Lung
- Lung Cancers
- Pulmonary Cancer
- Cancer, Pulmonary
- Cancers, Pulmonary
- Pulmonary Cancers
- Cancer of the Lung
- Cancer of Lung
|
Below are MeSH descriptors whose meaning is more general than "Lung Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Lung Neoplasms".
This graph shows the total number of publications written about "Lung Neoplasms" by people in this website by year, and whether "Lung Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 6 | 7 | 13 |
| 1995 | 11 | 5 | 16 |
| 1996 | 10 | 4 | 14 |
| 1997 | 9 | 0 | 9 |
| 1998 | 13 | 1 | 14 |
| 1999 | 8 | 4 | 12 |
| 2000 | 12 | 2 | 14 |
| 2001 | 12 | 5 | 17 |
| 2002 | 22 | 9 | 31 |
| 2003 | 32 | 13 | 45 |
| 2004 | 30 | 7 | 37 |
| 2005 | 35 | 11 | 46 |
| 2006 | 32 | 12 | 44 |
| 2007 | 41 | 10 | 51 |
| 2008 | 43 | 9 | 52 |
| 2009 | 36 | 4 | 40 |
| 2010 | 45 | 4 | 49 |
| 2011 | 54 | 11 | 65 |
| 2012 | 51 | 4 | 55 |
| 2013 | 59 | 5 | 64 |
| 2014 | 52 | 6 | 58 |
| 2015 | 74 | 9 | 83 |
| 2016 | 71 | 11 | 82 |
| 2017 | 65 | 3 | 68 |
| 2018 | 74 | 6 | 80 |
| 2019 | 76 | 7 | 83 |
| 2020 | 76 | 6 | 82 |
| 2021 | 87 | 3 | 90 |
| 2022 | 67 | 0 | 67 |
| 2023 | 70 | 0 | 70 |
| 2024 | 47 | 6 | 53 |
To return to the timeline,
click here.
Below are the most recent publications written about "Lung Neoplasms" by people in Profiles.
-
5-Hydroxymethylated Biomarkers in Cell-Free DNA Predict Occult Colorectal Cancer up to 36 Months Before Diagnosis in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. JCO Precis Oncol. 2024 Oct; 8:e2400277.
-
NF-?B represses retinoic acid receptor-mediated GPRC5A transactivation in lung epithelial cells to promote neoplasia. JCI Insight. 2024 10 08; 9(19).
-
Prognostic Factors in Limited-Stage Small Cell Lung Cancer: A Secondary Analysis of CALGB 30610-RTOG 0538. JAMA Netw Open. 2024 Oct 01; 7(10):e2440673.
-
Non-small-cell lung cancer. Nat Rev Dis Primers. 2024 Sep 26; 10(1):71.
-
Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2024 Sep 28; 404(10459):1240-1252.
-
Comparison of Measurement and Prognostic Power of SUV Between High-Definition and Standard PET Imaging in Non-Small Cell Lung Cancer Patients. J Nucl Med Technol. 2024 Sep 05; 52(3):229-233.
-
Atezolizumab Before and After Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer: A Phase II Nonrandomized Controlled Trial. JAMA Oncol. 2024 Sep 01; 10(9):1212-1219.
-
Recurrence of Non-Small Cell Lung Cancer With Visceral Pleural Invasion: A Secondary Analysis of a Randomized Clinical Trial. JAMA Oncol. 2024 Sep 01; 10(9):1179-1186.
-
Clinical and molecular correlates of tumor aneuploidy in metastatic non-small cell lung cancer. Sci Rep. 2024 08 21; 14(1):19375.
-
Randomized trial of anetumab ravtansine and pembrolizumab compared to pembrolizumab for mesothelioma. Lung Cancer. 2024 Sep; 195:107928.